Dermatologic findings in 2 patients with COVID-19

Ryan Rivera-Oyola; Merav Koschitzky; Rachel Printy; Stephanie Liu; Roselyn Stanger; Alexandra K. Golant; Mark Lebwohl

doi:10.1016/j.jdcr.2020.04.027

Dermatologic findings in 2 patients with COVID-19

Ryan Rivera-Oyola
, Merav Koschitzky
, Rachel Printy
, Stephanie Liu
, Roselyn Stanger
, Alexandra K. Golant
, Mark Lebwohl

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Original language	English
Pages (from-to)	537-539
Number of pages	3
Journal	JAAD Case Reports
Volume	6
Issue number	6
DOIs	https://doi.org/10.1016/j.jdcr.2020.04.027
State	Published - Jun 2020

Access to Document

10.1016/j.jdcr.2020.04.027

Cite this

@article{9d97de1a9f9049bd8e7e9acb7275c17c,

title = "Dermatologic findings in 2 patients with COVID-19",

author = "Ryan Rivera-Oyola and Merav Koschitzky and Rachel Printy and Stephanie Liu and Roselyn Stanger and Golant, \{Alexandra K.\} and Mark Lebwohl",

note = "Funding Information: Conflicts of interest: Dr Golant is an employee of Mount Sinai, a speaker for Regeneron and Sanofi Genzyme, and a consultant for AbbVie, Dermira, and Janssen. Dr Lebwohl is an employee of Mount Sinai and receives research funds from AbbVie; Amgen; Eli Lilly; Janssen Research \& Development, LLC; Novartis; Ortho Dermatologics; Regeneron-Sanofi; and UCB, Inc. He has been the principal investigator for numerous clinical trials but reports receiving no compensation. Drs Liu and Stanger and authors Rivera-Oyola, Koschitzky, and Printy have no conflicts of interest to declare. Funding sources: None.",

year = "2020",

month = jun,

doi = "10.1016/j.jdcr.2020.04.027",

language = "English",

volume = "6",

pages = "537--539",

journal = "JAAD Case Reports",

issn = "2352-5126",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Dermatologic findings in 2 patients with COVID-19

AU - Rivera-Oyola, Ryan

AU - Koschitzky, Merav

AU - Printy, Rachel

AU - Liu, Stephanie

AU - Stanger, Roselyn

AU - Golant, Alexandra K.

AU - Lebwohl, Mark

N1 - Funding Information: Conflicts of interest: Dr Golant is an employee of Mount Sinai, a speaker for Regeneron and Sanofi Genzyme, and a consultant for AbbVie, Dermira, and Janssen. Dr Lebwohl is an employee of Mount Sinai and receives research funds from AbbVie; Amgen; Eli Lilly; Janssen Research & Development, LLC; Novartis; Ortho Dermatologics; Regeneron-Sanofi; and UCB, Inc. He has been the principal investigator for numerous clinical trials but reports receiving no compensation. Drs Liu and Stanger and authors Rivera-Oyola, Koschitzky, and Printy have no conflicts of interest to declare. Funding sources: None.

PY - 2020/6

Y1 - 2020/6

UR - https://www.scopus.com/pages/publications/85085052726

U2 - 10.1016/j.jdcr.2020.04.027

DO - 10.1016/j.jdcr.2020.04.027

M3 - Article

AN - SCOPUS:85085052726

SN - 2352-5126

VL - 6

SP - 537

EP - 539

JO - JAAD Case Reports

JF - JAAD Case Reports

IS - 6

ER -